RAD-140 + MK-677 Stack: The Most Popular Bulking SARM Combination

The RAD-140 + MK-677 stack is the world's best-selling SARM bulking combination. Learn the complete protocol: RAD-140 for direct muscle anabolism + MK-677 for elevated growth hormone. Dosing, cycle length, managing hunger and water, PCT protocol, and expected results of 8-15 lbs gained.

N

Novo Pharma Research Team

Novo Pharma Research · peer-reviewed literature synthesis

19 min read
RAD-140 MK-677 stackbulking SARM stackRAD-140 cycleMK-677 growth hormoneSARM mass stack

RAD-140 + MK-677 Stack: The Most Popular Bulking SARM Combination

Understanding the Two Pathways

Pathway 1: Androgen Receptor Activation (RAD-140)

RAD-140 is a selective androgen receptor modulator that binds the AR with high affinity and tissue selectivity (muscle and bone over prostate). When RAD-140 occupies the androgen receptor in muscle cells, it triggers:

  • Increased nitrogen retention (muscle protein synthesis exceeds breakdown)
  • Enhanced satellite cell activation (muscle fiber repair and growth)
  • Increased myonuclear domain (each muscle cell can support more protein)
  • Strength and neuromuscular drive enhancement (CNS effects)

This is the direct anabolic signal — the same fundamental mechanism that testosterone and anabolic steroids exploit, but with greater tissue selectivity and fewer off-target effects.

Pathway 2: Growth Hormone Axis (MK-677)

MK-677 is a growth hormone secretagogue — technically neither a SARM nor a peptide. It is an orally-active ghrelin receptor (GHS-R1a) mimetic that stimulates the pituitary gland to release growth hormone (GH) in a pulsatile pattern.

When MK-677 elevates GH and subsequently IGF-1:

  • Protein synthesis rates increase (IGF-1 is independently anabolic)
  • Fat oxidation improves (GH promotes lipolysis)
  • Collagen synthesis increases (joint and tendon repair)
  • Sleep architecture improves (deeper REM and SWS phases)
  • Wound healing accelerates
  • Nutrient partitioning improves (calories directed toward muscle over fat)

A 2008 study by Nass et al. in the Journal of Clinical Endocrinology and Metabolism demonstrated that MK-677 elevated IGF-1 levels by approximately 40% in healthy elderly subjects over 2 years of continuous administration, with IGF-1 levels reaching those of healthy young adults.

Why Two Pathways > One

The androgen receptor pathway and the GH/IGF-1 pathway are synergistic but non-redundant:

  • AR activation builds muscle directly through transcriptional changes in muscle cells
  • GH/IGF-1 amplifies the building process by improving recovery, nutrient availability, and systemic anabolic tone
  • Together: you build muscle faster AND recover faster, creating a positive feedback loop where increased training capacity → more stimulus → more growth → better recovery → repeat

An analogy: RAD-140 is the construction crew building the house. MK-677 is the supply chain delivering materials faster and the rest breaks ensuring the crew shows up fresh every morning. Neither alone is as effective as both together.


The Complete Bulking Protocol

Standard Stack

CompoundDoseTimingDuration
RAD-14010-20mg/dayMorning8 weeks
MK-67715-25mg/dayBefore bed12-16 weeks

Dosing Details: RAD-140

ExperienceDoseNotes
First SARM cycle10mg/dayAssess response before escalating
Second cycle / intermediate15mg/daySweet spot for most users
Advanced20mg/dayDiminishing returns above this

Timing: Take RAD-140 in the morning. Its long half-life (~60 hours) means timing is flexible, but morning dosing aligns the mild stimulatory/aggression effect with training rather than sleep.

Dosing Details: MK-677

ExperienceDoseNotes
First time15mg/dayAppetite increase manageable
Standard20mg/dayOptimal GH elevation
Aggressive25mg/dayMaximum GH pulse, significant hunger

Timing: Take MK-677 30-60 minutes before bed. The GH pulse it induces synergizes with the natural nocturnal GH spike, and the pronounced hunger increase is managed by sleeping through it. Additionally, users report significantly improved sleep quality when dosing at night.

Why MK-677 Runs Longer Than RAD-140

This is a critical protocol detail that many sources overlook:

  • RAD-140 suppresses testosterone. It must be cycled (8 weeks) and followed by PCT or recovery.
  • MK-677 does NOT suppress testosterone. It can be run continuously or for extended periods (12-16 weeks) without hormonal consequences.

The optimal approach:

  1. Start MK-677 two weeks before RAD-140 (establishes elevated GH/IGF-1 baseline)
  2. Run both together for 8 weeks (the synergistic phase)
  3. Stop RAD-140 at week 8, begin PCT
  4. Continue MK-677 for 4-8 additional weeks through PCT and recovery

This extended MK-677 use helps preserve gains during PCT when testosterone is low and catabolic risk is highest. The continued GH/IGF-1 elevation provides anti-catabolic support while your HPTA recovers.

[Internal Link: /mk-677-ibutamoren/]


Expected Results: The Numbers

Conservative Expectations (RAD 10mg + MK 20mg, 8 weeks)

MetricExpected Result
Total weight gain8-12 lbs
Lean mass gain6-9 lbs
Water/glycogen2-4 lbs (drops post-cycle)
Strength increase20-30% on compound lifts
Body fat change-1-2% (recomp effect from GH)
Recovery improvementSignificant (training frequency can increase)
Sleep qualityNotably improved (MK-677 effect)

Aggressive Expectations (RAD 20mg + MK 25mg, 8 weeks)

MetricExpected Result
Total weight gain12-18 lbs
Lean mass gain8-13 lbs
Water/glycogen4-6 lbs
Strength increase25-40% on compound lifts
Body fat change-1-3%
RecoveryDramatically improved

Comparison: RAD-140 Alone vs RAD + MK-677

MetricRAD-140 SoloRAD + MK-677Difference
Lean mass5-8 lbs6-13 lbs+1-5 lbs
Strength+20-30%+25-35%+5%
RecoveryImprovedDramatically improvedSignificant
SleepUnchangedImprovedBeneficial
Total suppressionModerateModerate (same)No increase

The MK-677 addition provides approximately 20-40% more lean mass gain over RAD-140 alone, with zero additional hormonal suppression. This is the fundamental value proposition of the stack.


Managing MK-677 Side Effects

MK-677 is the compound in this stack that requires the most active management. While not suppressive, it has distinct effects that beginners must understand and plan for.

1. Increased Appetite (The Hunger)

The problem: MK-677 mimics ghrelin — the "hunger hormone." Most users experience significantly increased appetite within 1-3 days of starting.

The magnitude: Appetite increase ranges from mild (+10-15% intake desire) to dramatic (+30-50% intake desire). Individual variation is large.

Management strategies:

  • Dose before bed (sleep through peak hunger)
  • First 2 weeks are worst — appetite normalizes partially by week 3-4
  • Pre-plan meals with high protein and fiber (satiating) rather than high-carb/high-fat (easy to overeat)
  • Keep caloric surplus moderate (+300-500) — do not use MK-677 hunger as an excuse for a dirty bulk
  • Some users find 15mg produces minimal hunger while still elevating GH

The reframe: During a bulk, increased appetite is actually helpful. You NEED to eat above maintenance. MK-677 makes it effortless. The problem only arises if you let hunger drive you into a 1000+ calorie surplus, accumulating unnecessary fat.

2. Water Retention

The mechanism: Elevated GH increases sodium retention → fluid retention. Elevated insulin (from GH-induced insulin resistance) further promotes water retention.

What to expect:

  • 2-5 lbs of water weight in the first 2 weeks
  • Puffier face and extremities (especially morning)
  • Slightly blurred muscle definition

Management:

  • Sodium intake: keep moderate and consistent (don't oscillate high/low)
  • Potassium supplementation: 500-1000mg/day (balances sodium-driven retention)
  • Hydration: paradoxically, drinking MORE water reduces retention (signals kidneys to release)
  • Dandelion root extract: 500-1000mg/day (mild natural diuretic)
  • Time: water retention stabilizes by weeks 3-4 as the body adjusts

The truth: MK-677 water retention is cosmetically annoying but pharmacologically benign. It is not the pathological fluid accumulation that high-estrogen compounds produce. It resolves within 1-2 weeks of cessation.

3. Lethargy / Drowsiness

Mechanism: GH elevation causes fatigue in some users, particularly at higher doses.

Management: This is actually a benefit if you dose before bed — the "drowsiness" becomes deep, restorative sleep. Users who dose in the morning often complain of lethargy. Solution: always dose at night.

4. Blood Sugar / Insulin Resistance

Mechanism: Growth hormone is inherently anti-insulin. Chronic GH elevation from MK-677 can reduce insulin sensitivity over time.

Monitoring: Fasting glucose should be checked at mid-cycle bloodwork. If it exceeds 5.6 mmol/L (100 mg/dL), consider:

  • Reducing MK-677 dose
  • Adding berberine (500mg 2-3x/day — improves insulin sensitivity)
  • Ensuring cardiovascular exercise (3-4x/week — enhances glucose disposal)
  • Limiting refined carbohydrate intake

Risk level: At 20mg for 12-16 weeks, clinically significant insulin resistance is uncommon in young, active users with normal baseline glucose. It is more relevant for those with pre-existing metabolic syndrome, high body fat, or those running MK-677 continuously for 6+ months.

A study by Copinschi et al. (1997) in Neuroendocrinology found that MK-677 at 25mg/day for 7 days increased fasting glucose by approximately 0.3 mmol/L — a statistically significant but clinically manageable elevation.


PCT Protocol for the RAD + MK-677 Stack

What Needs PCT

  • RAD-140: Yes. Suppresses natural testosterone production.
  • MK-677: No. Non-hormonal. Does not require PCT. Can continue during PCT.

Standard PCT Protocol

  • When to start: 5-7 days after last RAD-140 dose (accounting for ~60-hour half-life)
  • Drug: Nolvadex (Tamoxifen)
  • Dose: 20mg/day
  • Duration: 4 weeks
  • Continue MK-677: Yes — keep running MK-677 through PCT at 15-20mg/day

Why Continue MK-677 Through PCT

During PCT, your testosterone is suppressed and recovering. This is the period of highest catabolism risk — the anabolic signal (RAD-140) is gone, and endogenous testosterone has not yet recovered. MK-677's continued GH/IGF-1 elevation provides:

  • Anti-catabolic support (IGF-1 preserves muscle independent of androgens)
  • Continued recovery enhancement (sleep quality maintained)
  • Nutrient partitioning support (calories still directed toward muscle)

Users who continue MK-677 through PCT consistently report better gain retention compared to those who stop everything simultaneously.

Post-PCT Timeline

WeekStatusAction
Week 9-10RAD cleared, PCT beginningNolvadex 20mg/day + MK-677 20mg/day
Week 11-12Mid-PCTContinue both. Get bloodwork at week 12.
Week 13PCT endingFinal week Nolvadex. Continue MK-677 if desired.
Week 14-16Recovery confirmationPost-PCT bloodwork. MK-677 optional taper/stop.

[Internal Link: /nolvadex-tamoxifen/] [Internal Link: /pct-supplements/]


Bloodwork Protocol

Essential Testing Schedule

TimingPurposeKey Panels
Pre-cycle (baseline)Establish all reference valuesFull hormone panel, metabolic panel, lipids, CBC, IGF-1, fasting glucose
Week 4 (mid-cycle)Monitor suppression + glucoseTotal T, Free T, LH, FSH, fasting glucose, liver enzymes
Day 5-7 post-RADAssess suppression severityTotal T, Free T, LH, FSH, E2
Week 4 of PCTConfirm recovery trajectoryTotal T, Free T, LH, FSH
2 weeks post-PCTFinal confirmationFull panel (compare to baseline)

MK-677 Specific Markers

  • IGF-1: Should be elevated 30-50% above baseline (confirms MK-677 is working)
  • Fasting glucose: Monitor for insulin resistance (should stay < 5.6 mmol/L)
  • Fasting insulin: Optional but informative (HOMA-IR calculation)
  • Prolactin: MK-677 can mildly elevate prolactin in some users

Canadian Bloodwork Access

In Canada, comprehensive bloodwork can be obtained through:

  • Family physician (may require clinical justification)
  • Private labs: LifeLabs, Dynacare (direct-to-consumer panels)
  • Online ordering services that ship to Canadian labs
  • Walk-in clinics (some will order hormone panels on request)

Cost for a full panel: approximately $200-350 CAD through private services. Budget this into your cycle cost — it is non-optional, not an add-on.


Training Optimization on RAD + MK-677

Volume Increase

The recovery enhancement from both RAD-140 (direct tissue repair signaling) and MK-677 (GH-mediated recovery + sleep quality) means you can handle significantly more training volume:

  • Increase weekly sets per muscle group by 25-40%
  • Training frequency: 5-6 days per week becomes sustainable
  • Two-a-day training becomes feasible for advanced athletes
  • Deload frequency can decrease (every 6-8 weeks instead of every 4-5)

Programming Recommendations

Weeks 1-4: Volume Accumulation

  • Progressive overload on compound lifts (add weight weekly)
  • 4-5 sets per exercise, 6-10 reps on compounds, 10-15 on accessories
  • Train each muscle group 2x per week minimum

Weeks 5-8: Intensity Peak

  • Push strength PRs (RAD-140's strength effects peak)
  • Increase top-set weight while maintaining volume
  • Add intensity techniques: rest-pause, drop sets, mechanical advantage sets
  • Capitalize on improved recovery to train aggressively

The Sleep Advantage

MK-677's improvement of sleep architecture is not cosmetic — it is functionally critical for muscle growth. The majority of GH release occurs during deep sleep (slow-wave sleep). MK-677 deepens this phase, creating a compounding cycle:

  1. MK-677 elevates GH → improves sleep quality
  2. Better sleep → more natural GH release during sleep
  3. Combined GH elevation → enhanced recovery
  4. Better recovery → more productive training
  5. More productive training → more growth stimulus

Users consistently report waking feeling more refreshed, requiring slightly less total sleep time for equivalent recovery, and having more vivid dreams (a marker of enhanced REM sleep).


Nutrition During the Stack

Caloric Requirements

This stack is designed for a caloric surplus. Do not run RAD + MK-677 in a deficit — you are wasting the growth potential of both compounds.

Recommended surplus: +300-500 calories above maintenance

The MK-677 hunger increase makes achieving surplus effortless. The challenge is avoiding EXCESSIVE surplus that accumulates unnecessary fat. Structure your eating:

Macronutrient Targets

MacroTargetRationale
Protein1.0-1.2g/lb bodyweightMaximum muscle protein synthesis support
Carbohydrates2-3g/lb bodyweightFuel training, support glycogen, leverage insulin sensitivity
Fat0.3-0.4g/lb bodyweightHormonal health, caloric density

MK-677 Hunger Management Strategy

  • Pre-bed dose + immediate sleep eliminates late-night hunger window
  • High-protein, high-fiber breakfast as first meal (controls appetite throughout day)
  • Pre-prepared meals prevent hunger-driven impulsive eating
  • Track calories even when appetite is high — the scale does not lie

Insulin Sensitivity Support

Given MK-677's potential to reduce insulin sensitivity:

  • Time carbohydrates around workouts (when insulin sensitivity is highest)
  • Include regular cardiovascular exercise (3-4x/week, 20-30 min)
  • Consider berberine (500mg with carb-heavy meals) if fasting glucose elevates
  • Apple cider vinegar (1 tbsp before meals) — modest but proven effect on postprandial glucose

Comparison to Other Bulking Stacks

RAD + MK-677 vs LGD + MK-677

FactorRAD + MK-677LGD + MK-677
Total massSimilar (8-15 lbs)Slightly more (9-16 lbs)
DrynessDrierWetter
StrengthHigherModerate
SuppressionModerateModerate (similar)
Water retentionMK-677 onlyMK-677 + LGD (more total)
Cognitive boostYes (RAD)No
Hair riskHigher (RAD)Lower (LGD)

Choose RAD + MK-677 if: You want drier gains, more strength, and cognitive boost. Choose LGD + MK-677 if: You want maximum size and are less concerned about water/aesthetics.

RAD + MK-677 vs Testosterone Cycle (500mg/week)

FactorRAD + MK-677Testosterone 500mg
Mass gain8-15 lbs15-25 lbs
Strength+25-35%+30-50%
Side effectsMildModerate (estrogen, hematocrit, etc.)
PCT difficultyModerateHarder
Injectable requiredNo (both oral)Yes
Hair riskModerateModerate-high
CostLowerLower
Legal status (Canada)Research chemicalControlled substance

The testosterone cycle produces more absolute results, but requires injection, causes estrogen-related side effects (gynecomastia risk, water retention, BP), and results in deeper HPTA suppression. The RAD + MK-677 stack is less effective in absolute terms but offers the convenience of oral dosing with a milder side effect profile.

[Internal Link: /testosterone-enanthate/]


Common Mistakes to Avoid

1. Running MK-677 for Only 8 Weeks

MK-677's GH/IGF-1 elevation takes 2-4 weeks to reach full steady-state effect. Running it for only 8 weeks means you get 4-6 weeks of peak effect. Run it for 12-16 weeks to maximize the benefit.

2. Dosing MK-677 in the Morning

Morning dosing causes daytime hunger spikes and potential lethargy. Evening dosing converts both "side effects" into benefits (hunger during sleep, drowsiness as improved sleep quality).

3. Dirty Bulking Because "MK-677 Makes Me Hungry"

MK-677 hunger is real, but using it as an excuse for 1500-calorie surplus guarantees unnecessary fat gain. The GH elevation does improve nutrient partitioning, but it does not override thermodynamics at extreme surpluses.

4. Skipping PCT Because "MK-677 Isn't Suppressive"

MK-677 is not suppressive — but RAD-140 IS. The stack requires PCT for the RAD-140 component regardless of MK-677's presence.

5. Stopping MK-677 When RAD-140 Stops

Continue MK-677 through PCT. The anti-catabolic GH/IGF-1 support during recovery is one of the stack's key advantages. Stopping both simultaneously sacrifices gain retention.


Frequently Asked Questions

Q: Can I take RAD-140 and MK-677 at the same time of day?

You can, but it is suboptimal. RAD-140 is best taken in the morning (mild stimulatory effect aligns with daytime activity). MK-677 is best taken before bed (sleep quality enhancement, hunger management). Splitting them maximizes each compound's unique advantages.

Q: How much of my gains will I keep after the cycle?

With proper PCT, continued MK-677 through recovery, and maintained training/nutrition: 70-85% of lean mass is typically retained. The weight that drops post-cycle is primarily water and glycogen (2-4 lbs), not muscle tissue. Users who crash-diet or stop training during PCT lose significantly more.

Q: Is MK-677 the same as injectable HGH?

No. MK-677 stimulates your pituitary to release MORE of your own GH in natural pulsatile patterns. Injectable HGH provides exogenous GH at flat, supraphysiological levels. MK-677 produces approximately 30-50% elevation of IGF-1 — injectable HGH at therapeutic doses produces 50-100%+ elevation. MK-677 is less potent but oral, cheaper, and maintains natural GH pulsatility. It is "GH optimization" rather than "GH replacement."

Q: Will this stack cause gynecomastia?

Neither RAD-140 nor MK-677 aromatizes to estrogen, so estrogen-mediated gynecomastia is not a direct risk. However, MK-677 can mildly elevate prolactin in some users, and elevated prolactin can theoretically contribute to breast tissue sensitivity. If nipple sensitivity develops, check prolactin levels. P5P (pyridoxal-5-phosphate, active vitamin B6) at 100-200mg/day effectively manages MK-677-induced prolactin elevation in most cases.

Q: Can beginners run this stack, or should they start with one compound?

Beginners CAN run this stack because MK-677 is non-hormonal — adding it does not increase the hormonal complexity of the cycle. The suppression profile is identical to RAD-140 alone. However, purists recommend running RAD-140 solo first (to isolate your response to it), then adding MK-677 on the second cycle. This approach provides clearer data on which compound produces which effects in your body.


Conclusion: The Stack That Earned Its Reputation

The RAD-140 + MK-677 combination did not become the world's best-selling SARM stack through marketing. It earned that position through a decade of users independently discovering what the pharmacology predicts: two independent anabolic pathways producing amplified results without amplified hormonal cost.

RAD-140 gives you the androgen receptor stimulation that directly builds muscle and drives strength. MK-677 gives you the growth hormone elevation that amplifies recovery, improves sleep, enhances nutrient partitioning, and preserves gains through PCT. Together, they create a synergy that consistently delivers 8-15 lbs of lean mass in 8 weeks — results that approach low-dose testosterone cycles without the needles, the estrogen management, or the deep suppression.

Run it smart. Get your bloodwork. Manage MK-677's hunger and water. Continue MK-677 through PCT. Train harder than you have ever trained (because you can now recover from it). And assess your results honestly at the end. For most users, this stack represents the highest-return SARM protocol available — the point where oral convenience, moderate risk, and genuine results intersect.

[Internal Link: /rad-140-testolone/] [Internal Link: /mk-677-ibutamoren/] [Internal Link: /sarm-stacks/]


Disclaimer: This article is for educational purposes only. SARMs and research chemicals are not approved for human consumption in Canada. MK-677 is an investigational drug without regulatory approval. Consult a healthcare professional before using any performance-enhancing compounds. Bloodwork monitoring is essential for any hormonal protocol.

References:

  1. Miller, C.P., et al. (2011). Design, synthesis, and preclinical characterization of the selective androgen receptor modulator (SARM) RAD140. ACS Medicinal Chemistry Letters, 2(2), 124-129.
  2. Nass, R., et al. (2008). Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Annals of Internal Medicine, 149(9), 601-611.
  3. Copinschi, G., et al. (1997). Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men. Journal of Clinical Endocrinology and Metabolism, 82(10), 3455-3463.
  4. Murphy, M.G., et al. (2001). Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. Journal of Clinical Endocrinology and Metabolism, 86(3), 1116-1125.
  5. Jayaraman, A., et al. (2014). Selective androgen receptor modulator RAD140 is neuroprotective in cultured neurons and kainate-lesioned male rats. Endocrinology, 155(4), 1398-1406.
Research chemical disclaimer

All compounds discussed and sold through Novo Pharma are intended strictly for laboratory and in-vitro research purposes. Products are not for human or animal consumption, not for use in food, cosmetics, or medicinal applications, and not for any therapeutic or diagnostic use.

The information on this page is provided for educational context and documents findings from published research. It is not medical advice, not a recommendation, and not a suggestion that any compound be used outside of a controlled research environment. Consult a qualified healthcare professional for any medical or health-related decision.

By purchasing, you confirm you are a qualified researcher, accept full responsibility for proper handling and disposal, and agree to use compounds in compliance with all applicable local, provincial, and federal laws.